Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 10;114(4):571–578. doi: 10.1093/jnci/djab225

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Figure 1. — Changes in the adjusted probability of treatment initiation within 30 days of metastatic diagnosis between COVID-19 and pre–COVID-19 periods. This figure displays the differential effect of the COVID-19 period on the probability of 30-day treatment initiation by cancer type, race, and age (years) among patients with newly diagnosed de novo or recurrent metastatic solid cancer. The error bars represent the 95% confidence intervals. NSCLC = non-small cell lung carcinoma; RCC = renal cell carcinoma; UCC = urothelial cell carcinoma.